ADMA Biologics Inc Analysis
| Analyst Ratings |
|
Average Target Price
|
5.13
|
|
Average Rating
|
4.75
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.08
|
-0.08
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.08
|
-0.07
|
0.01
|
12.50%
|
|
2022-03-31
|
-0.08
|
-0.13
|
-0.05
|
-62.50%
|
|
2021-12-31
|
-0.09
|
-0.09
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.14
|
-0.13
|
0.01
|
7.14%
|
|
2021-06-30
|
-0.15
|
-0.14
|
0.01
|
6.67%
|
|
2021-03-31
|
-0.17
|
-0.16
|
0.01
|
5.88%
|
|
2020-12-31
|
-0.16
|
-0.20
|
-0.04
|
-25.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.28
|
|
2021-12-31
|
-0.52
|
|
2020-12-31
|
-0.88
|
|
2019-12-31
|
-0.90
|
|
2018-12-31
|
-1.46
|
|
2017-12-31
|
-1.93
|
|
2016-12-31
|
-1.62
|
|
2015-12-31
|
-1.74
|
|
2014-12-31
|
-1.81
|
|
2013-12-31
|
-0.83
|